My watch list  

Metastatic Colorectal Cancer

News Metastatic Colorectal Cancer

  • Merck to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

    Merck announced a development agreement for investigational molecule abituzumab with SFJ Pharmaceuticals Group (SFJ), a US-based company focused on increasing R&D output and productivity through innovative models. “Our collaboration with SFJ illustrates Merck’s increasing focus on strategic partneri more

  • BRAF-mutant mCRC phase III trial initiated

    Merck announced with Array BioPharma Inc. and Pierre Fabre, the initiation of a prospective, randomized, global Phase III clinical trial of BRAF-mutant metastatic colorectal cancer (mCRC), investigating a new combination of Erbitux (cetuximab), a standard-of-care treatment for RAS wild-type mCRC, pl more

  • Merck and Biocartis to Collaborate

    Merck announced that it has signed a collaboration agreement with Biocartis for the development and commercialization of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC). The test will be developed on Biocartis’ innovative, fully automated molecular diagno more

All news on metastatic colorectal cancer

Publications Metastatic Colorectal Cancer

All publications on metastatic colorectal cancer
Related topics


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE